Tag:
Galenica
Latest Headlines
Latest Headlines
ALSO NOTED: Galenica share surge on committee approval; Progen to acquire CellGate; and much more...
> Shares of Galenica jumped 15 percent this morning after the company announced that an FDA advisory committee has endorsed its iron replacement therapy Ferinject/Injectafer. A formal decision is
Aspreva agrees to $915M buyout offer
Switzerland's Galenica is buying out Canada's Aspreva Pharmaceuticals for $915 million. The deal values Aspreva's shares at $26 each, a 16 percent premium from yesterday's close. The buyout comes
